The_DT Mason-Pfizer_NP Monkey_NP Virus_NP PPPY_NP and_CC PSAP_NP Motifs_NP Both_CC Contribute_NP to_TO Virus_NP Release_NP Late_NP (_( L_NP )_) domains_NNS are_VBP required_VBN for_IN the_DT efficient_JJ release_NN of_IN several_JJ groups_NNS of_IN enveloped_VBN viruses_NNS ._SENT Three_CD amino_NN acid_NN motifs_NNS have_VBP been_VBN shown_VBN to_TO provide_VB L-domain_NP function_NN ,_, namely_RB ,_, PPXY_NP ,_, PT/SAP_NP ,_, or_CC YPDL_NP ._SENT The_DT retrovirus_NN Mason-Pfizer_NN monkey_NN virus_NN (_( MPMV_NP )_) carries_VBZ closely_RB spaced_VBN PPPY_NP and_CC PSAP_NP motifs_NNS ._SENT Mutation_NN of_IN the_DT PPPY_JJ motif_NN results_NNS in_IN a_DT complete_JJ loss_NN of_IN virus_NN release_NN ._SENT Here_RB ,_, we_PP show_VBP that_IN the_DT PSAP_NP motif_NN acts_NNS as_IN an_DT additional_JJ L_NP domain_NN and_CC promotes_VBZ the_DT efficient_JJ release_NN of_IN MPMV_NP but_CC requires_VBZ an_DT intact_JJ PPPY_JJ motif_NN to_TO perform_VB its_PP$ function_NN ._SENT Examination_NN of_IN HeLaP4_NP cells_NNS expressing_VBG PSAP_NP mutant_JJ virus_NN by_IN electron_NN microscopy_NN revealed_VBD mostly_RB late_JJ budding_VBG structures_NNS and_CC chains_NNS of_IN viruses_NNS accumulating_VBG at_IN the_DT cell_NN surface_NN with_IN little_JJ free_JJ virus_NN ._SENT In_IN the_DT case_NN of_IN the_DT PPPY_JJ mutant_JJ virus_NN ,_, budding_VBG appeared_VBD to_TO be_VB mostly_RB arrested_VBN at_IN an_DT earlier_JJR stage_NN before_IN induction_NN of_IN membrane_NN curvature_NN ._SENT The_DT cellular_JJ protein_NN TSG101_NP ,_, which_WDT interacts_VBZ with_IN the_DT human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (_( HIV-1_NP )_) PTAP_NP L_NP domain_NN ,_, was_VBD packaged_VBN into_IN MPMV_NP in_IN a_DT PSAP-dependent_JJ manner_NN ._SENT Since_IN TSG101_NP is_VBZ crucial_JJ for_IN HIV-1_JJ release_NN ,_, this_DT result_NN suggests_VBZ that_IN the_DT Gag-TSG101_NP interaction_NN is_VBZ responsible_JJ for_IN the_DT virus_NN release_NN function_NN of_IN the_DT MPMV_NP PSAP_NP motif_NN ._SENT Nedd4_NP ,_, which_WDT has_VBZ been_VBN shown_VBN to_TO interact_VB with_IN viral_JJ PPPY_JJ motifs_NNS ,_, was_VBD also_RB detected_VBN in_IN MPMV_NP particles_NNS ,_, albeit_IN at_IN much_RB lower_JJR levels_NNS ._SENT Consistent_JJ with_IN a_DT role_NN of_IN VPS4A_NP in_IN the_DT budding_VBG of_IN both_DT PPPY_NP and_CC PTAP_NP motif-containing_NN viruses_NNS ,_, the_DT overexpression_NN of_IN ATPase-defective_NP GFP-VPS4A_NP fusion_NN proteins_NNS blocked_VBD both_DT wild-type_NN and_CC PSAP_NP mutant_JJ virus_NN release_NN ._SENT Retrovirus_NN assembly_NN and_CC release_NN are_VBP driven_VBN by_IN the_DT viral_JJ Gag_NP polyprotein_NN ,_, which_WDT contains_VBZ all_DT determinants_NNS necessary_JJ for_IN the_DT formation_NN of_IN virus-like_JJ particles_NNS ._SENT Within_IN Gag_NP ,_, an_DT interaction_NN domain_NN mediates_VBZ Gag-Gag_NP association_NN ,_, while_IN a_DT membrane_NN binding_VBG domain_NN directs_VBZ Gag_NP to_TO the_DT plasma_NN membrane_NN ._SENT Based_VBN on_IN the_DT sequence_NN of_IN Gag_NP assembly_NN and_CC membrane_NN association_NN ,_, two_CD major_JJ pathways_NNS of_IN virus_NN assembly_NN can_MD be_VB distinguished_VBN :_: betaretroviruses_NNS ,_, such_JJ as_IN Mason-Pfizer_NP monkey_NN virus_NN (_( MPMV_NP )_) and_CC mouse_VB mammary_JJ tumor_NN virus_NN (_( MMTV_NP )_) ,_, assemble_VBP immature_JJ procapsids_NNS in_IN the_DT cytoplasm_NN (_( B/D-type_NP assembly_NN )_) ._SENT These_DT procapsids_NNS are_VBP subsequently_RB transported_VBN to_TO the_DT plasma_NN membrane_NN ._SENT Other_JJ retroviruses_NNS ,_, e.g._FW ,_, the_DT lentivirus_NN human_JJ immunodeficiency_NN virus_NN (_( HIV_NP )_) ,_, form_NN electron-dense_NN assembly_NN complexes_NNS after_IN targeting_VBG Gag_NP to_TO the_DT plasma_NN membrane_NN (_( C-type_NP assembly_NN )_) ._SENT Irrespective_RB of_IN the_DT mode_NN of_IN Gag_NP assembly_NN ,_, however_RB ,_, virus_NN bud_NN formation_NN is_VBZ generally_RB initiated_VBN at_IN the_DT plasma_NN membrane_NN ._SENT The_DT efficient_JJ separation_NN of_IN the_DT bud_NN from_IN the_DT cell_NN membrane_NN has_VBZ been_VBN shown_VBN to_TO be_VB an_DT active_JJ process_NN which_WDT requires_VBZ so-called_JJ late_RB (_( L_NP )_) domains_NNS ._SENT During_IN or_CC after_IN budding_VBG ,_, the_DT virus_NN undergoes_VBZ maturation_NN ,_, i.e._FW ,_, the_DT viral_JJ protease_NN (_( PR_NP )_) cleaves_VBZ Gag_NP into_IN the_DT mature_JJ matrix_NN (_( MA_NP )_) ,_, capsid_NN (_( CA_NP )_) ,_, and_CC nucleocapsid_JJ (_( NC_NP )_) proteins_VBZ as_RB well_RB as_IN other_JJ products_NNS ,_, depending_VBG on_IN the_DT virus_NN ._SENT This_DT process_NN leads_VBZ to_TO the_DT condensation_NN of_IN the_DT viral_JJ core_NN and_CC is_VBZ essential_JJ for_IN virus_NN infectivity_NN ._SENT To_TO date_NN ,_, three_CD different_JJ sequence_NN motifs_NNS have_VBP been_VBN shown_VBN to_TO provide_VB L-domain_NP function_NN :_: PT/SAP_NP ,_, PPXY_NP ,_, and_CC YPDL_NP ._SENT While_IN L_NP domains_NNS have_VBP first_RB been_VBN described_VBN in_IN retroviral_JJ Gag_NP proteins_NNS ,_, they_PP are_VBP also_RB present_JJ in_IN the_DT M_NN and_CC matrix_NN proteins_NNS of_IN rhabdoviruses_NNS and_CC filoviruses_NNS ,_, respectively_RB ._SENT Most_JJS retroviruses_NNS except_IN lentiviruses_NNS contain_VBP a_DT PPXY_JJ motif_NN ,_, in_IN some_DT cases_NNS together_RB with_IN a_DT PT/SAP_NP motif_NN ._SENT In_IN contrast_NN ,_, most_JJS lentiviruses_NNS harbor_VBP only_RB the_DT PT/SAP_NP motif_NN ._SENT The_DT lentivirus_NN equine_JJ infectious_JJ anemia_NN virus_NN is_VBZ the_DT only_JJ virus_NN that_WDT has_VBZ been_VBN shown_VBN to_TO use_VB the_DT YPDL_NP motif_NN as_IN an_DT L_NP domain_NN ._SENT The_DT L-domain_NP sequence_NN is_VBZ generally_RB very_RB conserved_VBN ,_, and_CC even_RB subtle_JJ mutations_NNS result_NN in_IN the_DT retention_NN of_IN virus_NN buds_NNS at_IN the_DT plasma_NN membrane_NN (_( see_VB ,_, e.g._FW ,_, reference_NN )_) ._SENT The_DT budding_JJ structures_NNS arrested_VBN at_IN the_DT cell_NN surface_NN stay_VBP immature_JJ in_IN morphology_NN ._SENT Host_NN proteins_NNS have_VBP been_VBN identified_VBN that_IN directly_RB bind_NN to_TO the_DT different_JJ L-domain_NP motifs_NNS ,_, and_CC it_PP is_VBZ believed_VBN that_IN the_DT recruitment_NN of_IN these_DT proteins_NNS to_TO the_DT site_NN of_IN virus_NN budding_VBG ultimately_RB results_NNS in_IN the_DT membrane_NN fission_NN event_NN required_VBN for_IN virus_NN detachment_NN ._SENT The_DT exact_JJ set_NN of_IN factors_NNS needed_VBN ,_, however_RB ,_, and_CC the_DT mechanism_NN of_IN their_PP$ action_NN are_VBP not_RB understood_VBN ._SENT TSG101_NP ,_, which_WDT functions_VBZ in_IN the_DT vacuolar_JJ protein_NN sorting_VBG (_( Vps_NP )_) pathway_NN ,_, binds_VBZ to_TO the_DT PT/SAP_NP motif_NN of_IN HIV-1_NP and_CC HIV-2_NP ._SENT Similarly_RB to_TO mutations_NNS in_IN the_DT PT/SAP_NP motif_NN ,_, depletion_NN of_IN TSG101_NP from_IN virus-producing_NN cells_NNS causes_VBZ the_DT accumulation_NN of_IN virus_NN buds_NNS tethered_VBN to_TO the_DT cell_NN surface_NN ._SENT PPXY_JJ motifs_NNS are_VBP potential_JJ binding_JJ sites_NNS for_IN WW_NP domains_NNS ,_, and_CC the_DT WW_NP domain_NN containing_VBG Nedd-4_NP family_NN E3_NP ubiquitin_NN ligases_NNS has_VBZ been_VBN shown_VBN to_TO bind_VB to_TO retroviral_JJ PPXY_NP L_NP domains_NNS ._SENT A_DT function_NN of_IN ubiquitin_NN ligases_NNS in_IN retrovirus_NN budding_VBG is_VBZ supported_VBN by_IN the_DT observations_NNS that_IN a_DT small_JJ percentage_NN of_IN Gag_NP proteins_NNS within_IN purified_VBN HIV_NP and_CC murine_JJ leukemia_NN virus_NN (_( MLV_NP )_) is_VBZ monoubiquitinated_JJ and_CC that_IN large_JJ amounts_NNS of_IN free_JJ ubiquitin_NN are_VBP present_JJ inside_IN retroviruses_NNS ._SENT In_IN addition_NN ,_, the_DT intracellular_JJ depletion_NN of_IN free_JJ ubiquitin_NN by_IN treatment_NN with_IN proteasome_JJ inhibitors_NNS has_VBZ been_VBN shown_VBN to_TO block_VB release_NN of_IN HIV-1_NP ,_, HIV-2_NP ,_, and_CC Rous_NP sarcoma_NN virus_NN (_( RSV_NP )_) at_IN a_DT very_RB late_JJ stage_NN ._SENT In_IN the_DT case_NN of_IN RSV_NP ,_, this_DT block_NN could_MD be_VB partially_RB overcome_VBN by_IN fusing_VBG ubiquitin_NN to_TO the_DT C_NP terminus_NN of_IN Gag_NP ._SENT It_PP is_VBZ presently_RB not_RB known_VBN if_IN the_DT machinery_NN needed_VBD to_TO separate_VB viral_JJ and_CC cellular_JJ membranes_NNS is_VBZ identical_JJ or_CC at_IN least_JJS overlapping_VBG for_IN viruses_NNS containing_VBG different_JJ L_NP domains_NNS ._SENT The_DT observation_NN that_IN the_DT overexpression_NN of_IN ATPase-defective_NP VPS4A_NP proteins_NNS blocked_VBD release_NN not_RB only_RB of_IN HIV-1_NP ,_, carrying_VBG a_DT PTAP_NP motif_NN ,_, but_CC also_RB of_IN MLV_NP ,_, which_WDT functionally_RB depends_VBZ on_IN a_DT PPPY_JJ motif_NN ,_, suggested_VBD that_IN these_DT two_CD pathways_NNS may_MD utilize_VB the_DT same_JJ downstream_JJ effectors_NNS ._SENT Like_IN TSG101_NP ,_, VPS4_NP is_VBZ a_DT component_NN of_IN the_DT cellular_JJ Vps_NP pathway_NN ,_, normally_RB involved_VBN in_IN formation_NN of_IN multivesicular_JJ bodies_NNS (_( MVB_NP )_) ._SENT A_DT potential_JJ role_NN of_IN Nedd-4-like_JJ ubiquitin_NN ligases_NNS in_IN the_DT MVB_NP pathway_NN and_CC whether_IN the_DT PPXY_NP and_CC PT/SAP_NP motifs_NNS act_VBP in_IN a_DT redundant_JJ or_CC synergistic_JJ way_NN in_IN those_DT viruses_NNS where_WRB both_DT are_VBP found_VBN are_VBP unclear_JJ ._SENT Different_JJ L-domain_NP motifs_NNS have_VBP been_VBN shown_VBN to_TO be_VB at_IN least_JJS partially_RB exchangeable_JJ between_IN retroviruses_NNS ._SENT Some_DT viruses_NNS (_( e.g._FW ,_, HIV-1_NP )_) carry_VBP only_RB one_CD known_JJ L-domain_NP motif_NN ,_, while_IN several_JJ retroviruses_NNS (_( e.g._FW ,_, MPMV_NP and_CC human_JJ T-cell_NN leukemia_NN virus_NN type_NN 1_CD [_SYM HTLV-1_NP ]_SYM )_) as_RB well_RB as_IN Ebola_NP virus_NN and_CC vesicular_JJ stomatitis_NN virus_NN contain_VBP closely_RB spaced_VBN or_CC overlapping_JJ PPPY_NP and_CC PSAP_NP motifs_NNS ._SENT In_IN the_DT case_NN of_IN MPMV_NP ,_, PPPY_NP and_CC PSAP_NP motifs_NNS are_VBP found_VBN in_IN the_DT pp24/16_JJ domain_NN between_IN the_DT MA_NP and_CC CA_NP regions_NNS of_IN Gag_NP ._SENT Yasuda_NP et_FW al._FW showed_VBD that_IN the_DT PPPY_JJ motif_NN is_VBZ essential_JJ for_IN virus_NN release_NN ._SENT Thus_RB ,_, the_DT MPMV_NP PSAP_NP motif_NN alone_RB is_VBZ not_RB sufficient_JJ to_TO mediate_VB virus_NN release_NN ._SENT Here_RB ,_, we_PP report_VBP that_IN the_DT MPMV_NP PSAP_NP motif_NN acts_NNS as_IN an_DT additional_JJ L_NP domain_NN and_CC promotes_VBZ MPMV_NP release_NN in_IN a_DT PPPY_JJ motif-dependent_JJ manner_NN ._SENT Viruses_NNS that_WDT contain_VBP a_DT mutated_VBN PSAP_NP motif_NN were_VBD defective_JJ at_IN a_DT late_JJ stage_NN of_IN release_NN ,_, since_IN late_JJ budding_JJ structures_NNS and_CC chained_VBN procapsids_NNS accumulated_VBN at_IN the_DT cell_NN surface_NN ._SENT Consistent_JJ with_IN a_DT function_NN of_IN TSG101_NP in_IN MPMV_NP release_NN ,_, we_PP found_VBD endogenous_JJ TSG101_NN to_TO be_VB enriched_VBN in_IN purified_VBN MPMV_NP in_IN a_DT PSAP-dependent_JJ manner_NN ._SENT MPMV_NP expression_NN constructs_NNS ._SENT |_SYM The_DT pp24/16_JJ PPPY_NP and_CC PSAP_NP motifs_NNS were_VBD mutated_VBN in_IN the_DT context_NN of_IN pSHRM15_NN (_( provided_VBN by_IN E._NP Hunter_NP )_) ._SENT All_DT mutations_NNS were_VBD introduced_VBN by_IN standard_JJ PCR_NP mutagenesis_NN ,_, and_CC amplified_VBN fragments_NNS were_VBD sequenced_JJ ._SENT A_DT new_JJ MPMV_NP expression_NN plasmid_NP (_( pMPMV_NP )_) was_VBD constructed_VBN to_TO achieve_VB high_JJ levels_NNS of_IN virus_NN production_NN after_IN transient_JJ transfection_NN ._SENT To_TO this_DT end_NN ,_, the_DT MPMV_NP proviral_JJ sequence_NN (_( wild-type_NN [_SYM wt_NN ]_SYM or_CC mutant_JJ )_) was_VBD excised_VBN from_IN the_DT respective_JJ pSHRM15_NN plasmids_NNS and_CC cloned_VBN into_IN the_DT EcoRI_NP site_NN of_IN pcDNA3.1/Zeo(-)_NN (_( Invitrogen_NP )_) ._SENT The_DT region_NN between_IN the_DT pcDNA3.1/Zeo(-)_NN and_CC MPMV_NP transcription_NN start_NN sites_NNS was_VBD deleted_VBN by_IN PCR_NP ._SENT Detailed_JJ cloning_VBG procedures_NNS are_VBP available_JJ on_IN request_NN ._SENT The_DT resulting_VBG constructs_NNS carrying_VBG the_DT PPPY_NP ,_, PSAP_NP ,_, and_CC double_JJ mutations_NNS were_VBD designated_VBN pMPMV/PY(-)_NN ,_, pMPMV/PP(-)_NN ,_, and_CC pMPMV/2x(-)_NN ,_, respectively_RB ._SENT pSHRM15_NN derivatives_NNS were_VBD termed_VBN analogously_RB ._SENT Cell_NN lines_NNS and_CC transfections_NNS ._SENT |_SYM HeLaP4_NP and_CC 293T_JJ cells_NNS were_VBD maintained_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP medium_NN (_( DMEM_NP )_) containing_VBG 10_CD %_NN fetal_JJ calf_NN serum_NN and_CC antibiotics_NNS ._SENT For_IN labeling_VBG experiments_NNS and_CC analysis_NN by_IN electron_NN microscopy_NN (_( EM_NP )_) ,_, HeLaP4_NP cells_NNS were_VBD transfected_VBN with_IN FuGENE_NP 6_CD (_( Roche_NP )_) as_IN instructed_VBN by_IN the_DT manufacturer_NN ._SENT All_DT other_JJ transfections_NNS were_VBD carried_VBN out_RP by_IN the_DT calcium_NN phosphate_NN precipitation_NN method_NN ._SENT Metabolic_JJ labeling_VBG ._SENT |_SYM For_IN pulse-chase_NN experiments_NNS ,_, 4_CD x_SYM 106_CD HeLaP4_NP cells_NNS were_VBD transfected_VBN with_IN 20_CD mug_NN of_IN the_DT indicated_JJ plasmid_NN ._SENT Twenty-four_NP hours_NNS after_IN transfection_NN ,_, cells_NNS were_VBD detached_VBN by_IN using_VBG phosphate-buffered_JJ saline_NN (_( PBS_NP )_) containing_VBG 15_CD mM_NP EDTA_NP ,_, washed_VBD ,_, and_CC starved_VBN for_IN 20_CD min_NN in_IN methionine-free_JJ medium_NN (_( ICN_NP )_) containing_VBG 2_CD %_NN fetal_JJ calf_NN serum_NN ._SENT Then_RB ,_, cells_NNS were_VBD pulse-labeled_VBN for_IN 30_CD min_NN with_IN [_SYM 35S]methionine_JJ (_( 2_CD mCi/ml_NN ;_: SJ-5050_NP ,_, Amersham_NP )_) ._SENT The_DT pulse_NN period_NN was_VBD ended_VBN by_IN adjusting_VBG the_DT medium_NN to_TO 1_CD mM_NP unlabeled_JJ methionine_NN (_( Sigma_NP )_) ,_, followed_VBN by_IN removal_NN of_IN the_DT labeling_VBG medium_NN ._SENT Aliquots_NNS were_VBD chased_VBN in_IN DMEM_NP containing_VBG 0.4_CD mM_NP methionine_NN for_IN the_DT indicated_JJ period_NN of_IN time_NN ._SENT For_IN overnight_RB labeling_VBG ,_, 4_CD x_SYM 105_CD cells_NNS were_VBD transfected_VBN with_IN 4_CD mug_NN of_IN plasmid_NP ._SENT Thirty_CD hours_NNS posttransfection_NN ,_, cells_NNS were_VBD rinsed_VBN with_IN PBS_NP and_CC incubated_VBD with_IN [_SYM 35S]methionine_JJ (_( 0.1_CD mCi/ml_NN ,_, diluted_VBN as_IN above_JJ ;_: SJ-5050_NP ,_, Amersham_NP )_) for_IN 12_CD h._NN Subsequent_JJ to_TO pulse-chase_NN or_CC overnight_JJ labeling_VBG ,_, cells_NNS were_VBD washed_VBN with_IN PBS_NP and_CC lysed_VBN in_IN RIPA_NP buffer_NN (_( 50_CD mM_NP Tris_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 150_CD mM_NP NaCl_NP ,_, 1_CD %_NN NP-40_NP ,_, 0.5_CD %_NN sodium_NN deoxycholate_NN ,_, 0.1_CD %_NN sodium_NN dodecyl_JJ sulfate_NN [_SYM SDS_NP ]_SYM )_) ._SENT Cell_NN lysates_NNS were_VBD cleared_VBN by_IN centrifugation_NN (_( 13,000_CD x_SYM g_NN for_IN 15_CD min_NN )_) and_CC preblocked_JJ by_IN using_VBG a_DT mixture_NN of_IN three_CD preimmune_NN sera_NN and_CC protein_NN A_NP Sepharose_NP (_( Amersham_NP )_) (_( 1_CD h_NN at_IN 4C_JJ )_) ._SENT In_IN the_DT case_NN of_IN the_DT pulse-chase_NN experiments_NNS ,_, virus-containing_NN media_NNS were_VBD directly_RB lysed_VBN by_IN addition_NN of_IN 5x_NP RIPA_NP buffer_NN ._SENT After_IN overnight_RB labeling_VBG ,_, media_NNS were_VBD passaged_VBN through_IN 450-nm-pore-size_JJ filters_NNS and_CC virus_NN was_VBD sedimented_VBN through_IN sucrose_NN cushions_NNS (_( 20_CD %_NN [_SYM wt/vol_NN ]_SYM sucrose_NN in_IN PBS_NP )_) by_IN ultracentrifugation_NN (_( 90_CD min_NN at_IN 192,000_CD x_NN g_NN )_) and_CC lysed_VBN in_IN RIPA_NP buffer_NN ._SENT All_DT samples_NNS were_VBD immunoprecipitated_VBN by_IN using_VBG anti-MPMV_NP CA_NP antiserum_NN ._SENT The_DT immunoprecipitates_NNS were_VBD resolved_VBN by_IN SDS-polyacrylamide_NP gel_NN electrophoresis_NN (_( PAGE_NP )_) ._SENT Gels_NNS were_VBD fixed_VBN in_IN 30_CD %_NN methanol-10_NN %_NN acetic_JJ acid_NN and_CC dried_VBN ._SENT Labeled_VBN viral_JJ proteins_NNS were_VBD quantified_VBN by_IN using_VBG a_DT Bio-Rad_NP Personal_NP FX_NP Phosphorimager_NP and_CC Bio-Rad_NP Quantity_NP One_CD software_NN ._SENT Virus_NN purification_NN ._SENT |_SYM Virus_NP was_VBD prepared_VBN from_IN 293T_JJ cells_NNS transiently_RB transfected_VBN with_IN pMPMV_NN or_CC pMPMV/PP(-_NN )_) ._SENT Twelve_CD hours_NNS after_IN transfection_NN ,_, cells_NNS were_VBD rinsed_VBN with_IN PBS_NP ,_, and_CC the_DT medium_NN was_VBD replaced_VBN ._SENT Virus-containing_NP medium_NN was_VBD harvested_VBN 36_CD h_NN after_IN transfection_NN and_CC filtered_VBN through_IN a_DT 450-nm-pore-size_JJ filter_NN ._SENT Virus_NN was_VBD pelleted_VBN through_IN sucrose_NN cushions_NNS by_IN ultracentrifugation_NN (_( 60_CD min_NN at_IN 53,000_CD x_NN g_NN )_) ,_, resuspended_VBN in_IN 0.8_CD ml_NN of_IN PBS_NP ,_, and_CC loaded_VBN onto_IN a_DT 6_CD to_TO 18_CD %_NN Optiprep_NN gradient_NN as_RB described_VBD previously_RB ._SENT The_DT visible_JJ virus_NN band_NN was_VBD isolated_VBN and_CC diluted_VBN with_IN PBS_NP ._SENT Virus_NN was_VBD recovered_VBN by_IN ultracentrifugation_NN (_( 30_CD min_NN at_IN 164,000_CD x_NN g_NN )_) ._SENT Purity_NN of_IN the_DT preparation_NN was_VBD monitored_VBN by_IN silver_NN staining_VBG and_CC evaluated_VBN based_VBN on_IN the_DT loss_NN of_IN albumin_NN ._SENT For_IN external_JJ digestion_NN of_IN viral_JJ particles_NNS with_IN trypsin_NN ,_, sucrose_NN pellets_NNS were_VBD resuspended_VBN in_IN 0.1_CD mg_NN of_IN trypsin/ml_NN (_( ICN_NP )_) in_IN PBS_NP and_CC incubated_VBN at_IN 30C_JJ for_IN 30_CD min_NN ._SENT When_WRB virus_NN was_VBD lysed_VBN with_IN 0.1_CD %_NN Triton_NP X-100_NP before_IN trypsinization_NN ,_, a_DT complete_JJ loss_NN of_IN the_DT viral_JJ CA_NP band_NN was_VBD observed_VBN by_IN Western_NP blotting_VBG ._SENT Western_JJ blotting_VBG and_CC antibodies_NNS ._SENT |_SYM Western_NP blotting_VBG was_VBD performed_VBN by_IN using_VBG standard_JJ procedures_NNS ._SENT The_DT following_VBG primary_JJ antibodies_NNS were_VBD used_VBN :_: rabbit_NN anti-MPMV_NP CA_NP (_( provided_VBN by_IN T._NP Ruml_NP )_) (_( 1:1,000_LS )_) ;_: mouse_NN anti-TSG101-4A10_NN from_IN GeneTex_NP (_( 1:100_CD )_) ;_: rabbit_NN anti-Nedd-4_NN from_IN Becton_NP Dickinson_NP Biosciences_NP (_( 1:5,000_CD )_) ;_: rabbit_VB anti-green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) that_WDT was_VBD raised_VBN against_IN bacterially_RB expressed_VBN GFP_NP (_( 1:1,000_CD )_) ;_: and_CC rabbit_NN anti-14-3-3gamma_NN from_IN Santa_NP Cruz_NP (_( 1:1,000_CD )_) ._SENT EM_NN ._SENT |_SYM HeLaP4_NP cells_NNS (_( 1_CD x_SYM 106_CD )_) were_VBD transfected_VBN with_IN 8_CD mug_NN of_IN wt_NN or_CC mutant_JJ pMPMV_NN ._SENT At_IN 48_CD h_NN after_IN transfection_NN ,_, cells_NNS were_VBD gently_RB rinsed_VBN with_IN PBS_NP and_CC fixed_VBN with_IN ice_NN cold_JJ 2.5_CD %_NN glutaraldehyde_NN in_IN 0.05_CD M_NP sodium_NN cacodylate_NN (_( pH_NN 7.2_CD )_) for_IN 20_CD min_NN on_IN ice_NN ._SENT Fixed_VBN cells_NNS were_VBD scraped_VBN from_IN the_DT plates_NNS ,_, collected_VBN by_IN low-speed_NN centrifugation_NN (_( 200_CD x_SYM g_NN for_IN 10_CD min_NN at_IN 4C_JJ )_) ,_, successively_RB stained_VBN with_IN 2_CD %_NN osmium_NN tretroxide_NN and_CC 0.5_CD %_NN uranyl_NN acetate_NN ,_, and_CC processed_VBN for_IN ultrathin_NN sectioning_VBG ._SENT Micrographs_NNS were_VBD taken_VBN with_IN a_DT Zeiss_NP EM-10_NP electron_NN microscope_NN at_IN 80_CD kV_NN ._SENT The_DT magnification_NN indicator_NN was_VBD routinely_RB controlled_VBN by_IN the_DT use_NN of_IN a_DT grating_JJ replica_NN ._SENT The_DT PPPY_NP and_CC PSAP_NP motifs_NNS both_CC contribute_VB to_TO MPMV_NP release_NN ._SENT |_SYM To_TO facilitate_VB the_DT biochemical_JJ analysis_NN of_IN MPMV_NP release_NN ,_, a_DT novel_JJ MPMV_NP expression_NN plasmid_NN was_VBD constructed_VBN ._SENT To_TO this_DT end_NN ,_, the_DT MPMV_NP transcription_NN start_NN site_NN was_VBD placed_VBN under_IN the_DT control_NN of_IN a_DT CMV_NP promoter_NN such_JJ that_IN the_DT resulting_VBG transcripts_NNS are_VBP identical_JJ to_TO those_DT derived_VBN from_IN the_DT LTR_NP promoter_NN ._SENT The_DT new_JJ plasmid_NP (_( pMPMV_NP )_) and_CC the_DT parental_JJ construct_NN (_( pSHRM15_NN )_) were_VBD transfected_VBN into_IN HeLaP4_NP cells_NNS ,_, and_CC cell_NN extracts_VBZ and_CC virus_NN released_VBN into_IN the_DT growth_NN medium_NN were_VBD analyzed_VBN by_IN Western_NP blotting_VBG 24_CD h_NN after_IN transfection_NN ._SENT The_DT same_JJ pattern_NN of_IN Gag_NP and_CC CA_NP proteins_NNS was_VBD detected_VBN in_IN both_DT cases_NNS ._SENT Transfection_NN of_IN pMPMV_NP ,_, however_RB ,_, reproducibly_RB yielded_VBD significantly_RB higher_JJR levels_NNS of_IN Gag_NP protein_NN expression_NN and_CC virus_NN release_NN than_IN transfection_NN of_IN pSHRM15_NN (_( Fig._NN ,_, compare_VBP lanes_NNS 1_CD and_CC 3_CD to_TO lanes_NNS 2_CD and_CC 4_CD )_) ._SENT In_IN agreement_NN with_IN previously_RB published_VBN results_NNS ,_, intracellular_JJ processing_NN of_IN Gag_NP was_VBD observed_VBN for_IN both_DT constructs_NNS ._SENT The_DT extent_NN of_IN intracellular_JJ processing_NN did_VBD not_RB correlate_VB with_IN the_DT relative_JJ level_NN of_IN Gag_NP expression_NN ._SENT Within_IN its_PP$ pp24/16_JJ domain_NN ,_, MPMV_NP Gag_NP carries_VBZ a_DT PSAP_NP motif_NN four_CD amino_NN acids_NNS downstream_JJ of_IN a_DT PPPY_JJ motif_NN ._SENT To_TO evaluate_VB the_DT relative_JJ contribution_NN of_IN the_DT two_CD motifs_NNS to_TO MPMV_NP release_NN ,_, we_PP individually_RB mutated_VBD the_DT PPPY_JJ motif_NN to_TO PGAA_NP and_CC mutated_VBD the_DT PSAP_NP motif_NN to_TO AGAP_NP ._SENT The_DT mutations_NNS were_VBD introduced_VBN into_IN plasmids_NNS pMPMV_NN and_CC pSHRM15_NN ._SENT In_IN addition_NN ,_, we_PP constructed_VBD plasmids_NNS containing_VBG both_DT mutations_NNS ._SENT The_DT amino_NN acid_NN substitutions_NNS were_VBD chosen_VBN based_VBN on_IN published_VBN data_NNS and_CC should_MD result_VB in_IN complete_JJ inactivation_NN of_IN the_DT respective_JJ motif_NN ._SENT To_TO determine_VB the_DT efficiency_NN of_IN wt_NN and_CC mutant_JJ virus_NN release_NN ,_, HeLaP4_NP cells_NNS were_VBD transfected_VBN with_IN the_DT indicated_JJ plasmids_NNS and_CC ,_, 36_CD h_NN after_IN transfection_NN ,_, metabolically_RB labeled_VBN with_IN [_SYM 35S]methionine_JJ for_IN 12_CD h._NN After_IN the_DT labeling_VBG period_NN ,_, cells_NNS were_VBD lysed_VBN ._SENT Virus_NN was_VBD collected_VBN by_IN centrifugation_NN through_IN sucrose_NN cushions_NNS ._SENT Cell_NN extracts_VBZ and_CC virus_NN samples_NNS were_VBD subjected_VBN to_TO immunoprecipitation_NN with_IN an_DT antiserum_NN against_IN the_DT MPMV_NP CA_NP protein_NN followed_VBD by_IN SDS-PAGE_NN and_CC phosphorimage_NN analysis_NN ._SENT The_DT result_NN of_IN a_DT representative_JJ experiment_NN is_VBZ shown_VBN in_IN Fig._NN ._SENT Transfection_NN of_IN wt_NP pMPMV_NP yielded_VBD the_DT typical_JJ pattern_NN of_IN cell-associated_JJ Gag_NP and_CC CA_NP proteins_NNS and_CC caused_VBD the_DT release_NN of_IN virus_NN into_IN the_DT growth_NN medium_NN (_( Fig._NN ,_, lane_NN 1_CD )_) ._SENT It_PP should_MD be_VB noted_VBN that_IN all_DT virus_NN samples_NNS contained_VBD only_RB completely_RB processed_VBN CA_NP and_CC no_DT precursor_NN or_CC intermediate_JJ processing_NN products_NNS ,_, independent_JJ of_IN the_DT processing_NN defect_NN observed_VBN in_IN transfected_JJ cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Mutation_NN of_IN the_DT PPPY_JJ motif_NN resulted_VBN in_IN a_DT pronounced_JJ impairment_NN of_IN intracellular_JJ Gag_NP processing_NN and_CC a_DT defect_NN in_IN particle_NN release_NN (_( Fig._NN ,_, lane_NN 2_CD )_) ._SENT Gag_NN and_CC a_DT protein_NN with_IN slightly_RB lower_JJR mobility_NN than_IN Gag_NP (_( see_VB below_IN )_) accumulated_VBN in_IN PY(-)-transfected_JJ cells_NNS ,_, while_IN the_DT amount_NN of_IN processed_JJ CA_NP protein_NN was_VBD reduced_VBN ._SENT Analysis_NN of_IN the_DT virus_NN fraction_NN (_( Fig._NN ,_, lower_JJR panel_NN )_) revealed_VBD that_IN the_DT PPPY_JJ mutant_NN displayed_VBD a_DT strong_JJ defect_NN in_IN virus_NN release_NN ._SENT This_DT result_NN is_VBZ in_IN agreement_NN with_IN the_DT report_NN by_IN Yasuda_NP et_FW al._FW ,_, who_WP also_RB observed_VBD a_DT complete_JJ loss_NN of_IN virus_NN release_NN as_RB well_RB as_IN a_DT defect_NN in_IN Gag_NP processing_NN for_IN a_DT PPPY_JJ mutant_NN ._SENT Analysis_NN of_IN PSAP_NP mutant-transfected_JJ cells_NNS showed_VBD a_DT slight_JJ impairment_NN of_IN processing_NN and_CC a_DT significant_JJ reduction_NN in_IN virus_NN release_NN (_( Fig._NN ,_, lane_NN 3_CD )_) ._SENT Thus_RB ,_, the_DT PSAP_NP motif_NN cannot_MD substitute_VB for_IN the_DT PPPY_JJ motif_NN ,_, but_CC it_PP acts_VBZ as_IN an_DT additional_JJ L_NP domain_NN and_CC contributes_VBZ to_TO the_DT efficient_JJ release_NN of_IN MPMV_NP ._SENT The_DT phenotype_NN of_IN PSAP_NP inactivation_NN was_VBD less_RBR pronounced_VBN than_IN that_DT of_IN the_DT PPPY_JJ mutation_NN ._SENT Consistent_JJ with_IN the_DT absolute_JJ dependence_NN of_IN MPMV_NP release_NN on_IN the_DT intact_JJ PPPY_JJ motif_NN ,_, the_DT PPPY_NP and_CC PSAP_NP motif_NN double_JJ mutant_NN behaved_VBD like_IN the_DT PPPY_JJ mutant_NN (_( Fig._NN ,_, lane_NN 4_CD )_) ._SENT It_PP has_VBZ been_VBN suggested_VBN that_IN the_DT magnitude_NN of_IN the_DT defect_NN in_IN virus_NN release_NN caused_VBN by_IN L-domain_NP mutations_NNS may_MD correlate_VB with_IN the_DT level_NN of_IN Gag_NP expression_NN ._SENT The_DT described_VBN experiments_NNS were_VBD performed_VBN with_IN a_DT CMV-driven_NP high-level_JJ expression_NN plasmid_NN transfected_VBN by_IN lipofection_NN ._SENT To_TO exclude_VB the_DT possibility_NN that_IN the_DT intermediate_JJ phenotype_NN of_IN the_DT PSAP_NP mutant_NN was_VBD a_DT result_NN of_IN high_JJ levels_NNS of_IN expression_NN ,_, we_PP repeated_VBD the_DT experiment_NN by_IN using_VBG transfection_NN of_IN pSHRM15_NN into_IN HeLaP4_NP cells_NNS by_IN calcium_NN phosphate_NN precipitation_NN (_( Fig._NN ,_, lanes_NNS 1_CD to_TO 3_CD )_) ._SENT As_IN observed_VBN for_IN transfection_NN of_IN the_DT pMPMV_NP plasmid_NP ,_, the_DT PPPY_NP mutant_JJ Gag_NP protein_NN remained_VBD largely_RB unprocessed_JJ and_CC exhibited_VBN a_DT block_NN to_TO virus_NN release_NN (_( Fig._NN ,_, lane_NN 2_CD )_) ._SENT Intracellular_JJ processing_NN of_IN Gag_NP and_CC virus_NN release_NN were_VBD also_RB significantly_RB reduced_VBN in_IN the_DT case_NN of_IN the_DT PSAP_NP mutant_NN but_CC were_VBD less_RBR impaired_VBN than_IN for_IN the_DT PPPY_JJ mutant_NN (_( Fig._NN ,_, compare_VBP lanes_NNS 1_CD to_TO 3_CD )_) ._SENT Accordingly_RB ,_, the_DT intermediate_JJ phenotype_NN of_IN the_DT PSAP_NP mutant_NN is_VBZ not_RB due_JJ to_TO overexpression_NN ._SENT To_TO quantify_VB the_DT relative_JJ efficiencies_NNS of_IN wt_NN and_CC mutant_JJ virus_NN release_NN from_IN pMPMV-transfected_JJ cells_NNS ,_, the_DT virus-associated_JJ CA_NP signal_NN was_VBD related_VBN to_TO the_DT sum_NN of_IN the_DT signals_NNS of_IN the_DT intracellular_JJ and_CC virus-associated_JJ CA-containing_NP proteins_NNS ._SENT Only_RB the_DT three_CD major_JJ CA-containing_NP bands_NNS (_( namely_RB ,_, Gag_NP ,_, the_DT protein_NN migrating_VBG slightly_RB above_IN Gag_NP ,_, and_CC processed_VBD CA_NP )_) detected_VBD in_IN cell_NN extracts_VBZ were_VBD quantified_VBN ._SENT The_DT obtained_VBN numbers_NNS were_VBD normalized_VBN for_IN the_DT methionine_NN content_NN of_IN the_DT respective_JJ proteins_NNS ._SENT The_DT protein_NN migrating_VBG above_IN Gag_NP was_VBD assumed_VBN to_TO carry_VB the_DT same_JJ number_NN of_IN methionines_NNS as_IN Gag_NP ._SENT These_DT quantifications_NNS indicated_VBD that_IN virus_NN release_NN is_VBZ reduced_VBN by_IN approximately_RB fivefold_JJ in_IN the_DT case_NN of_IN the_DT PPPY_JJ and_CC double_JJ mutants_NNS ,_, while_IN PSAP_NP inactivation_NN resulted_VBD in_IN a_DT reduction_NN of_IN virus_NN release_NN by_IN roughly_RB 30_CD %_NN ._SENT Rescue_NN of_IN L-domain_NP mutant_JJ Gag_NP proteins_NNS ._SENT |_SYM It_PP has_VBZ been_VBN reported_VBN that_IN RSV_NP L-domain_NP mutant_JJ Gag_NP protein_NN can_MD be_VB rescued_VBN into_IN virus-like_JJ particles_NNS by_IN coexpression_NN of_IN Gag_NP protein_NN carrying_VBG an_DT intact_JJ L_NP domain_NN ._SENT These_DT results_NNS suggest_VBP that_IN only_RB a_DT minor_JJ fraction_NN of_IN Gag_NP molecules_NNS of_IN a_DT budding_JJ virion_NN needs_VBZ to_TO carry_VB an_DT L_NP domain_NN ._SENT To_TO test_VB the_DT release_NN efficiency_NN of_IN mixed_JJ populations_NNS of_IN MPMV_NP Gag_NP proteins_VBZ ,_, we_PP cotransfected_VBD equal_JJ amounts_NNS of_IN mutant_JJ and_CC wt_JJ plasmids_NNS and_CC analyzed_VBN and_CC quantified_VBN CA-reactive_JJ proteins_NNS in_IN cell_NN and_CC virus_NN extracts_VBZ 24_CD h_NN post_NN transfection_NN (_( Fig._NN ,_, lanes_NNS 5_CD to_TO 7_CD and_CC Fig._NN )_) ._SENT Cotransfection_NN of_IN the_DT wt_JJ plasmid_NN with_IN either_DT PPPY_JJ or_CC double_JJ mutant_JJ pMPMV_NN resulted_VBN in_IN a_DT 40_CD %_NN reduction_NN of_IN virus_NN release_NN compared_VBN to_TO wt_NN virus_NN (_( Fig._NN ,_, compare_VBP lanes_NNS 1_CD ,_, 5_CD ,_, and_CC 7_CD ;_: Fig._NN )_) ,_, indicating_VBG that_IN only_RB a_DT partial_JJ rescue_NN occurred_VBD ._SENT A_DT similar_JJ analysis_NN for_IN the_DT PSAP_NP motif_NN mutant_NN was_VBD not_RB conclusive_JJ ,_, because_IN differences_NNS in_IN virus_NN release_NN were_VBD too_RB small_JJ (_( Fig._NN ,_, compare_VBP lanes_NNS 1_CD and_CC 6_CD ;_: Fig._NN )_) ._SENT The_DT experiments_NNS shown_VBN in_IN the_DT previous_JJ section_NN suggested_VBD that_IN both_DT motifs_NNS contribute_VBP to_TO MPMV_NP release_NN ._SENT To_TO test_VB whether_IN the_DT PPPY_NP and_CC PSAP_NP motifs_NNS can_MD complement_VB each_DT other_JJ in_IN trans_NNS or_CC need_VBP to_TO be_VB present_JJ on_IN the_DT same_JJ polyprotein_NN ,_, we_PP performed_VBD cotransfection_NN experiments_NNS ._SENT Transfecting_VBG equal_JJ amounts_NNS of_IN pMPMV_NN plasmids_NNS carrying_VBG either_CC the_DT PPPY_NP or_CC the_DT PSAP_NP mutation_NN yielded_VBD higher_JJR levels_NNS of_IN virus_NN release_NN than_IN transfection_NN of_IN the_DT same_JJ amount_NN of_IN either_DT variant_NN alone_RB (_( Fig._NN compare_NN lanes_NNS 2_CD ,_, 3_CD and_CC 8_CD ;_: Fig._NN )_) ._SENT A_DT partial_JJ rescue_NN of_IN virus_NN release_NN was_VBD also_RB observed_VBN by_IN Western_JJ blot_NN analysis_NN of_IN virus_NN produced_VBN from_IN HeLaP4_NP cells_NNS cotransfected_VBN with_IN PPPY_NP and_CC PSAP_NP mutant_JJ pSHRM15_NN ._SENT Thus_RB ,_, both_DT motifs_NNS can_MD complement_VB each_DT other_JJ in_IN trans_NNS under_IN low-_NN and_CC high-expression_NN conditions_NNS ._SENT Gag_NN lacking_VBG the_DT PPPY_JJ motif_NN trans-dominant-negatively_RB inhibits_VBZ wt_JJ virus_NN release_NN ._SENT |_SYM Since_IN virus_NN release_NN is_VBZ not_RB completely_RB rescued_VBN by_IN expressing_VBG equal_JJ amounts_NNS of_IN PPPY_JJ mutant_JJ and_CC wt_JJ Gag_NP polyproteins_NNS ,_, we_PP determined_VBD whether_IN this_DT mutant_NN has_VBZ a_DT dominant-negative_JJ influence_NN on_IN wt_JJ virus_NN release_NN ._SENT wt_NN and_CC PPPY_JJ mutant_JJ pSHRM15_NN derivatives_NNS were_VBD cotransfected_VBN at_IN a_DT ratio_NN of_IN 1:1_CD and_CC 1:2_CD ._SENT In_IN all_DT cases_NNS ,_, the_DT total_JJ amount_NN of_IN transfected_JJ DNA_NN was_VBD adjusted_VBN to_TO 15_CD mug_NN by_IN using_VBG empty_JJ vector_NN ._SENT As_RB noted_VBD above_RB ,_, cotransfection_NN of_IN equal_JJ amounts_NNS of_IN PPPY_JJ mutant_JJ and_CC wt_JJ proviral_JJ plasmids_NNS (_( 5_CD mug_NN each_DT )_) did_VBD not_RB yield_VB more_JJR virus_NN production_NN than_IN transfection_NN of_IN 5_CD mug_NN of_IN wt_NN plasmid_NN alone_RB (_( Fig._NN ,_, compare_VBP lanes_NNS 2_CD and_CC 5_CD )_) ._SENT When_WRB wt_NN and_CC mutant_JJ plasmids_NNS were_VBD cotransfected_VBN at_IN a_DT ratio_NN of_IN 1:2_CD ,_, virus_NN release_NN was_VBD reduced_VBN to_TO nearly_RB undetectable_JJ levels_NNS ,_, even_RB though_IN higher_JJR levels_NNS of_IN Gag_NP protein_NN were_VBD observed_VBN in_IN cell_NN extracts_VBZ ._SENT Cotransfection_NN of_IN wt_NN and_CC PPPY_JJ mutant_JJ plasmids_NNS also_RB did_VBD not_RB restore_VB intracellular_JJ Gag_NP processing_NN ,_, since_IN only_JJ Gag_NP and_CC the_DT protein_NN slightly_RB above_IN Gag_NP were_VBD detected_VBN in_IN cell_NN lysates_NNS (_( Fig._NN ,_, lanes_NNS 5_CD and_CC 6_CD )_) ._SENT The_DT dominant-negative_JJ effect_NN of_IN the_DT PPPY_NP mutant_JJ Gag_NP protein_NN was_VBD also_RB evident_JJ when_WRB high_JJ levels_NNS of_IN expression_NN were_VBD used_VBN (_( Fig._NN ,_, lanes_NNS 7_CD to_TO 9_CD )_) and_CC is_VBZ therefore_RB independent_JJ of_IN the_DT Gag_NP expression_NN level_NN ._SENT In_IN addition_NN ,_, we_PP confirmed_VBD our_PP$ finding_NN by_IN quantitative_JJ Western_NP blotting_VBG (_( data_NNS not_RB shown_VBN )_) ._SENT Taken_VBN together_RB ,_, these_DT results_NNS suggest_VBP that_IN a_DT molar_JJ excess_NN of_IN PPPY_NP mutant_JJ Gag_NP polyproteins_NNS over_IN wt_NP Gag_NP has_VBZ a_DT dominant-negative_JJ influence_NN on_IN virus_NN production_NN ._SENT We_PP also_RB tested_VBD whether_IN cotransfection_NN of_IN the_DT MPMV_NP PSAP_NP mutant_NN or_CC of_IN a_DT HIV-1_NP L-domain_NP mutant_NN with_IN the_DT respective_JJ wt_NN plasmid_NN inhibited_VBD virus_NN release_NN ._SENT In_IN both_DT cases_NNS ,_, no_DT dominant-negative_JJ effect_NN on_IN virus_NN release_NN was_VBD observed_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT Analysis_NN of_IN wt_NN and_CC mutant_JJ Gag_NP processing_NN kinetics_NNS ._SENT |_SYM As_RB shown_VBN above_JJ ,_, intracellular_JJ processing_NN of_IN the_DT PPPY_JJ and_CC double-mutant_JJ Gag_NP polyproteins_NNS was_VBD significantly_RB impaired_VBN ._SENT To_TO analyze_VB the_DT processing_NN kinetics_NN of_IN wt_NN and_CC mutant_JJ Gag_NP proteins_NNS and_CC to_TO determine_VB whether_IN the_DT protein_NN migrating_VBG slightly_RB above_IN Gag_NP represents_VBZ a_DT posttranslational_JJ modification_NN of_IN Gag_NP ,_, we_PP performed_VBD pulse-chase_NN experiments_NNS ._SENT For_IN this_DT ,_, we_PP transfected_VBD HeLaP4_NP cells_NNS with_IN wt_NN or_CC mutant_JJ pMPMV_NN constructs_NNS ._SENT Twenty-four_NP hours_NNS after_IN transfection_NN ,_, cells_NNS were_VBD pulse-labeled_VBN with_IN [_SYM 35S]methionine_JJ for_IN 30_CD min_NN and_CC chased_VBD for_IN the_DT times_NNS indicated_VBD ._SENT Cell_NN and_CC virus_NN extracts_VBZ were_VBD immunoprecipitated_VBN with_IN anti-CA_NN antibodies_NNS ._SENT wt_NP Gag_NP processing_NN and_CC release_NN kinetics_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT Directly_RB after_IN the_DT pulse_NN ,_, the_DT Gag_NP polyprotein_NN was_VBD the_DT predominant_JJ band_NN detected_VBN (_( lane_NN 1_CD )_) ,_, and_CC processing_VBG to_TO CA_NP became_VBD clearly_RB detectable_JJ after_IN a_DT 1-h_NP chase_NN (_( lane_NN 3_CD )_) ._SENT Most_JJS of_IN the_DT intracellular_JJ Gag_NP was_VBD processed_VBN to_TO CA_NP after_IN 8_CD h._NP Release_NP of_IN virus_NN particles_NNS containing_VBG processed_JJ CA_NP was_VBD detected_VBN after_IN 1_CD h_NN and_CC increased_VBN over_IN the_DT entire_JJ chase_NN period_NN ._SENT A_DT comparison_NN of_IN wt_NN and_CC mutant_JJ Gag_NP processing_NN kinetics_NN is_VBZ shown_VBN in_IN Fig._NN ._SENT Similar_JJ amounts_NNS of_IN Gag_NP polyproteins_NNS were_VBD observed_VBN in_IN all_DT cases_NNS after_IN the_DT pulse_NN period_NN ,_, and_CC the_DT protein_NN migrating_VBG above_IN Gag_NP was_VBD not_RB detected_VBN in_IN these_DT samples_NNS (_( Fig._NN ,_, lanes_NNS 1_CD to_TO 4_CD )_) ._SENT Processing_NN kinetics_NNS of_IN the_DT PSAP_NP variant_NN were_VBD largely_RB similar_JJ to_TO the_DT wt_NN polyprotein_NN (_( Fig._NN ,_, compare_VBP lanes_NNS 5_CD and_CC 7_CD and_CC lanes_NNS 9_CD and_CC 11_CD )_) ._SENT A_DT significant_JJ processing_NN defect_NN was_VBD observed_VBN for_IN the_DT PY(-)_NP variant_NN and_CC for_IN the_DT double_JJ mutant_NN ,_, with_IN both_DT exhibiting_VBG reduced_VBN levels_NNS of_IN CA_NP after_IN 2-h_NP and_CC 8-h_JJ chase_JJ periods_NNS (_( lanes_NNS 6_CD and_CC 8_CD and_CC lanes_NNS 10_CD and_CC 12_CD )_) ._SENT Furthermore_RB ,_, the_DT protein_NN migrating_VBG slightly_RB slower_JJR than_IN Gag_NP (_( marked_VBN by_IN an_DT arrow_NN in_IN lanes_NNS 6_CD ,_, 8_CD ,_, 10_CD ,_, and_CC 12_LS )_) became_VBD detectable_JJ in_IN cells_NNS transfected_VBN with_IN the_DT PPPY_JJ or_CC double_JJ mutant_NN after_IN a_DT chase_JJ period_NN of_IN 2_CD h_NN and_CC remained_VBD present_JJ after_IN 8_CD h._NN Therefore_RB ,_, this_DT product_NN corresponds_VBZ to_TO a_DT posttranslationally_RB modified_VBN version_NN of_IN Gag_NP ._SENT We_PP hypothesize_VBP that_IN it_PP represents_VBZ Gag_NP lacking_VBG the_DT proline-rich_JJ C-terminal_JJ p4_NN domain_NN ._SENT Cleavage_NN of_IN p4_NN by_IN the_DT viral_JJ PR_NP may_MD result_VB in_IN altered_JJ migration_NN of_IN the_DT protein_NN in_IN SDS-PAGE_NP ._SENT CA-containing_VBG cleavage_NN products_NNS migrating_VBG slower_JJR than_IN their_PP$ precursors_NNS have_VBP been_VBN described_VBN for_IN other_JJ retroviruses_NNS ._SENT Alternatively_RB ,_, the_DT product_NN migrating_VBG just_RB above_IN Gag_NP could_MD result_VB from_IN a_DT posttranslational_JJ modification_NN of_IN Gag_NP other_JJ than_IN processing_NN ._SENT EM_NN analysis_NN of_IN virus_NN assembly_NN and_CC release_NN ._SENT |_SYM Deletion_NN of_IN either_CC the_DT PPPY_NP or_CC the_DT PSAP_NP motif_NN impaired_VBN MPMV_NP release_NN ,_, but_CC the_DT effect_NN of_IN the_DT PSAP_NP mutation_NN was_VBD much_RB less_RBR pronounced_JJ ,_, and_CC virus_NN production_NN was_VBD still_RB observed_VBN in_IN this_DT case_NN ._SENT Analysis_NN of_IN particle_NN formation_NN by_IN EM_NP is_VBZ a_DT more_RBR direct_JJ way_NN to_TO determine_VB virus_NN release_NN at_IN the_DT morphological_JJ level_NN ._SENT We_PP therefore_RB performed_VBD thin-section_JJ EM_JJ analysis_NN of_IN HeLaP4_NP cells_NNS transfected_VBN with_IN wt_NN ,_, PPPY_JJ mutant_NN ,_, PSAP_NP mutant_NN ,_, or_CC double-mutant_JJ pMPMV_NN ._SENT In_IN all_DT cases_NNS ,_, the_DT typical_JJ sites_NNS of_IN intracellular_JJ assembly_NN of_IN immature_JJ procapsids_NNS were_VBD observed_VBN (_( shown_VBN representatively_RB for_IN cells_NNS transfected_VBN with_IN wt_JJ pMPMV_NN in_IN Fig._NN )_) ._SENT Furthermore_RB ,_, thin_JJ sections_NNS of_IN cells_NNS transfected_VBN with_IN the_DT wt_NP plasmid_NP contained_VBD many_JJ procapsids_NNS budding_VBG from_IN the_DT plasma_NN membrane_NN as_RB well_RB as_IN numerous_JJ mature_JJ and_CC immature_JJ virions_NNS ._SENT In_IN contrast_NN ,_, no_DT mature_JJ virions_NNS were_VBD detected_VBN in_IN thin_JJ sections_NNS of_IN cells_NNS transfected_VBN with_IN the_DT PPPY_NP mutant_JJ MPMV_NP ._SENT Instead_RB ,_, many_JJ immature_JJ procapsids_NNS accumulated_VBN underneath_IN the_DT plasma_NN membrane_NN and_CC appeared_VBD to_TO be_VB arrested_VBN at_IN an_DT early_JJ stage_NN of_IN bud_NN formation_NN ._SENT Typical_JJ late_JJ budding_JJ structures_NNS connected_VBN to_TO the_DT plasma_NN membrane_NN by_IN a_DT thin_JJ membrane_NN stalk_NN as_IN well_RB as_RB chained_VBN budding_JJ structures_NNS containing_VBG more_JJR than_IN one_CD procapsid_NN were_VBD also_RB present_JJ ,_, indicating_VBG that_IN the_DT early_JJ budding_JJ arrest_NN was_VBD overcome_VBN by_IN some_DT procapsids_NNS ._SENT Interestingly_RB ,_, in_IN several_JJ cells_NNS ,_, procapsids_NNS were_VBD found_VBN to_TO decorate_VB intracellular_JJ vesicles_NNS ._SENT Again_RB ,_, the_DT majority_NN of_IN these_DT procapsids_NNS failed_VBD to_TO initiate_VB bud_NN formation_NN ,_, and_CC no_RB bulging_VBG of_IN the_DT membrane_NN was_VBD observed_VBN ._SENT Thin-section_NP EM_NP analysis_NN of_IN cells_NNS transfected_VBN with_IN PSAP_NP mutant_JJ pMPMV_NN revealed_VBD a_DT different_JJ phenotype_NN ._SENT In_IN this_DT case_NN ,_, we_PP observed_VBD predominantly_RB late_RB immature_JJ budding_JJ structures_NNS ,_, many_JJ of_IN which_WDT were_VBD tethered_VBN to_TO each_DT other_JJ ._SENT Some_DT of_IN these_DT budding_JJ chains_NNS containing_VBG multiple_JJ procapsids_NNS were_VBD apparently_RB released_VBN from_IN the_DT cell_NN (_( Fig._NN ,_, upper_JJ right_NN )_) ._SENT Less_RBR extracellular_JJ particles_NNS were_VBD observed_VBN than_IN in_IN the_DT case_NN of_IN wt_NP pMPMV_NP ,_, but_CC some_DT mature_JJ virions_NNS containing_VBG a_DT condensed_JJ core_NN were_VBD detected_VBN (_( e.g._FW ,_, Fig._NN ,_, middle_JJ )_) ._SENT For_IN a_DT more_RBR quantitative_JJ determination_NN of_IN the_DT late_JJ defect_NN of_IN the_DT PSAP_NP variant_NN ,_, the_DT relative_JJ abundance_NN of_IN different_JJ budding_JJ structures_NNS and_CC free_JJ mature_JJ and_CC immature_JJ particles_NNS was_VBD counted_VBN for_IN wt_NP and_CC PSAP_NP mutant_JJ pMPMV-transfected_JJ cells_NNS ._SENT This_DT analysis_NN confirmed_VBD that_IN much_RB less_JJR mature_JJ virus_NN was_VBD observed_VBN in_IN the_DT case_NN of_IN the_DT PSAP_NP variant_NN ,_, and_CC the_DT amount_NN of_IN total_JJ cell-free_JJ virus_NN detected_VBD accounted_VBN for_IN only_RB 16_CD %_NN of_IN all_DT procapsids_NNS ,_, compared_VBN to_TO 60_CD %_NN for_IN the_DT wt_JJ constructs_NNS ._SENT On_IN the_DT other_JJ hand_NN ,_, the_DT relative_JJ abundance_NN of_IN budding_VBG structures_NNS and_CC virus_NN chains_NNS was_VBD increased_VBN in_IN the_DT case_NN of_IN the_DT PSAP_NP variant_NN ._SENT Only_RB 7_CD %_NN of_IN wt_NN procapsids_NNS were_VBD found_VBN in_IN virus_NN chains_NNS attached_VBN to_TO the_DT plasma_NN membrane_NN ,_, while_IN 26_CD %_NN of_IN PSAP_NP mutant_JJ procapsids_NNS were_VBD found_VBN in_IN such_JJ chains_NNS ._SENT Nearly_RB one-half_JJ of_IN the_DT chains_NNS containing_VBG multiple_JJ procapsids_NNS were_VBD apparently_RB released_VBN from_IN the_DT cell_NN ,_, i.e._FW ,_, no_DT connection_NN to_TO the_DT plasma_NN membrane_NN was_VBD visible_JJ ._SENT The_DT relative_JJ abundance_NN of_IN immature_JJ procapsids_NNS was_VBD also_RB significantly_RB higher_JJR for_IN the_DT PSAP_NP variant_NN ,_, indicating_VBG that_IN maturation_NN is_VBZ impaired_VBN in_IN this_DT case_NN ._SENT Taken_VBN together_RB ,_, these_DT results_NNS showed_VBD that_IN the_DT PSAP_NP mutant_NN is_VBZ indeed_RB defective_JJ at_IN the_DT stage_NN of_IN virus_NN release_NN ._SENT Interestingly_RB ,_, the_DT budding_JJ arrest_NN in_IN the_DT case_NN of_IN the_DT PSAP_NP variant_NN appeared_VBD to_TO be_VB at_IN a_DT later_JJR stage_NN than_IN in_IN the_DT PPPY_JJ variant_NN ,_, with_IN more_JJR advanced_JJ budding_JJ structures_NNS extending_VBG further_RBR away_RB from_IN the_DT plane_NN of_IN the_DT plasma_NN membrane_NN ._SENT As_RB in_IN the_DT biochemical_JJ experiments_NNS described_VBD above_RB ,_, the_DT double_JJ mutant_NN was_VBD indistinguishable_JJ from_IN the_DT PPPY_JJ mutant_NN at_IN the_DT morphological_JJ level_NN as_IN well_RB ._SENT TSG101_NP and_CC Nedd-4_NP are_VBP incorporated_VBN into_IN MPMV_NP particles_NNS ._SENT |_SYM The_DT interaction_NN of_IN the_DT HIV-1_NP PT/SAP_NP motif_NN with_IN TSG101_NP has_VBZ been_VBN shown_VBN to_TO be_VB essential_JJ for_IN HIV-1_JJ release_NN ,_, and_CC the_DT binding_NN of_IN Nedd-4-like_JJ proteins_NNS to_TO the_DT PPPY_JJ motif_NN is_VBZ presumed_VBN to_TO be_VB necessary_JJ for_IN the_DT function_NN of_IN this_DT late_JJ motif_NN ._SENT Accordingly_RB ,_, the_DT cellular_JJ binding_JJ partners_NNS should_MD be_VB recruited_VBN to_TO the_DT budding_JJ site_NN and_CC may_MD be_VB incorporated_VBN into_IN virions_NNS ._SENT The_DT overexpression_NN of_IN a_DT segment_NN of_IN TSG101_NP by_IN transfection_NN led_VBN to_TO incorporation_NN of_IN this_DT protein_NN into_IN HIV-1_JJ particles_NNS ._SENT To_TO test_VB whether_IN endogenous_JJ cellular_JJ TSG101_NP or_CC Nedd-4_NP are_VBP incorporated_VBN into_IN MPMV_NP virions_NNS ,_, we_PP analyzed_VBD highly_RB purified_VBN particle_NN preparations_NNS ._SENT To_TO this_DT end_NN ,_, 293T_JJ cells_NNS were_VBD transfected_VBN with_IN either_DT wt_NN or_CC a_DT PSAP_NP mutant_JJ pMPMV_NN ._SENT Media_NNS were_VBD gathered_VBN 36_CD h_NN after_IN transfection_NN and_CC filtered_VBN ,_, and_CC virus_NN was_VBD centrifuged_VBN through_IN cushions_NNS of_IN 20_CD %_NN sucrose_NN ._SENT Virus_NN samples_NNS were_VBD further_RBR purified_VBN by_IN velocity_NN gradient_JJ centrifugation_NN as_RB described_VBD previously_RB ._SENT The_DT visible_JJ virus_NN band_NN was_VBD collected_VBN and_CC diluted_VBN ,_, and_CC virus_NN was_VBD recovered_VBN by_IN ultracentrifugation_NN ._SENT Purity_NN of_IN samples_NNS was_VBD evaluated_VBN by_IN silver_NN staining_VBG ._SENT Judging_VBG from_IN the_DT silver-stained_JJ gel_NN ,_, the_DT general_JJ protein_NN content_NN and_CC the_DT degree_NN of_IN processing_NN were_VBD very_RB similar_JJ for_IN wt_NP and_CC PSAP_NP mutant_JJ virus_NN ._SENT The_DT viral_JJ Gag-derived_NP proteins_NNS represented_VBD the_DT major_JJ constituents_NNS of_IN the_DT virion_NN ._SENT To_TO examine_VB the_DT presence_NN of_IN TSG101_NP in_IN purified_VBN MPMV_NP ,_, similar_JJ amounts_NNS of_IN wt_NP and_CC PSAP_NP mutant_JJ virus_NN (_( the_DT same_JJ ratio_NN used_VBN in_IN Fig._NN ,_, lanes_NNS 1_CD and_CC 3_CD )_) were_VBD probed_VBN for_IN incorporation_NN of_IN endogenous_JJ TSG101_NP by_IN Western_NP blotting_VBG ._SENT TSG101_NN was_VBD readily_RB detected_VBN in_IN wt_JJ virus_NN preparations_NNS ,_, while_IN the_DT amount_NN of_IN TSG101_NP was_VBD significantly_RB reduced_VBN in_IN the_DT PSAP_NP mutant_JJ virus_NN preparation_NN (_( Fig._NN ,_, lanes_NNS 3_CD and_CC 4_CD )_) ,_, and_CC no_DT Tsg101_NP was_VBD detected_VBN in_IN parallel_JJ preparations_NNS from_IN the_DT medium_NN of_IN mock-transfected_JJ cells_NNS (_( Fig._NN ,_, lanes_NNS 3_CD and_CC 4_CD )_) ._SENT The_DT data_NNS in_IN Fig._NN slightly_RB exaggerate_VB the_DT amount_NN of_IN TSG101_JJ present_NN in_IN PSAP_NP mutant_JJ virus_NN preparations_NNS ,_, because_IN more_JJR PSAP_NP mutant_JJ virus_NN than_IN wt_NN virus_NN was_VBD loaded_VBN (_( compare_NN Fig._NN ,_, lanes_NNS 1_CD and_CC 3_CD or_CC Fig._NN ,_, lanes_NNS 3_CD and_CC 4_CD )_) ._SENT Quite_RB clearly_RB ,_, however_RB ,_, TSG101_NP was_VBD present_JJ in_IN PSAP_NP mutant_JJ virus_NN preparations_NNS ,_, albeit_IN at_IN a_DT reduced_VBN level_NN ._SENT To_TO determine_VB whether_IN other_JJ cytosolic_JJ proteins_NNS were_VBD nonspecifically_RB incorporated_VBN into_IN MPMV_NP particles_NNS ,_, we_PP probed_VBD for_IN the_DT protein_NN 14-3-3gamma_NP ,_, which_WDT localizes_VBZ mostly_RB to_TO the_DT cytosol_NN (_( data_NNS not_RB shown_VBN )_) ._SENT While_IN the_DT 14-3-3_CD protein_NN was_VBD highly_RB abundant_JJ in_IN cells_NNS ,_, it_PP was_VBD completely_RB absent_JJ from_IN virus_NN preparations_NNS ._SENT Thus_RB ,_, TSG101_NP is_VBZ clearly_RB enriched_VBN in_IN particle_NN preparations_NNS compared_VBN to_TO cell_NN extracts_VBZ ,_, while_IN other_JJ cytosolic_JJ proteins_NNS are_VBP largely_RB excluded_VBN ._SENT The_DT incorporation_NN of_IN TSG101_NP into_IN MPMV_NP was_VBD confirmed_VBN by_IN analysis_NN of_IN virions_NNS that_WDT had_VBD been_VBN treated_VBN with_IN trypsin_NN ,_, which_WDT degrades_VBZ proteins_NNS outside_JJ of_IN the_DT virion_NN ,_, but_CC did_VBD not_RB reduce_VB the_DT amount_NN of_IN TSG101_NP in_IN the_DT preparation_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT PPPY_JJ motif_NN binding_VBG protein_NN Nedd-4_NN was_VBD readily_RB detected_VBN in_IN cell_NN lysates_NNS (_( Fig._NN ,_, lanes_NNS 1_CD and_CC 2_CD )_) ,_, but_CC a_DT protein_NN migrating_VBG at_IN the_DT position_NN of_IN intact_JJ Nedd-4_NP was_VBD detected_VBN only_RB in_IN small_JJ amounts_NNS in_IN wt_NP and_CC PSAP_NP mutant_JJ virus_NN preparations_NNS (_( Fig._NN ,_, lanes_NNS 3_CD and_CC 4_CD )_) ._SENT The_DT stronger_JJR signal_NN in_IN lane_JJ 4_CD than_IN in_IN lane_JJ 3_CD probably_RB reflects_VBZ the_DT higher_JJR amount_NN of_IN virus_NN loaded_VBN for_IN the_DT PSAP_NP mutant_NN (_( compare_NN Fig._NN ,_, lanes_NNS 1_CD and_CC 3_CD )_) ._SENT Besides_IN intact_JJ Nedd-4_NP ,_, several_JJ other_JJ reactive_JJ proteins_NNS were_VBD detected_VBN with_IN Nedd-4_NP antiserum_NN in_IN virus_NN preparations_NNS ._SENT Some_DT of_IN these_DT proteins_NNS may_MD correspond_VB to_TO cross-reaction_NN with_IN (_( overloaded_VBN )_) viral_JJ proteins_NNS or_CC have_VBP also_RB been_VBN detected_VBN in_IN cell_NN lysates_NNS of_IN untransfected_JJ cells_NNS (_( not_RB shown_VBN )_) ,_, but_CC this_DT does_VBZ not_RB account_VB for_IN the_DT protein_NN with_IN an_DT apparent_JJ molecular_JJ mass_NN of_IN 50_CD kDa_NN (_( Fig._NN ,_, arrow_NN )_) ,_, which_WDT was_VBD not_RB present_JJ in_IN parallel_JJ preparations_NNS from_IN mock-transfected_JJ cells_NNS (_( Fig._NN ,_, arrow_NN )_) ._SENT The_DT presence_NN of_IN Nedd-4_NP and_CC the_DT smaller_JJR immunoreactive_JJ products_NNS inside_IN MPMV_NP virions_NNS was_VBD also_RB confirmed_VBN by_IN analysis_NN of_IN trypsin-treated_JJ virus_NN (_( data_NNS not_RB shown_VBN )_) ._SENT VPS4A_NP is_VBZ required_VBN for_IN wt_NP and_CC PSAP_NP mutant_JJ MPMV_NP release_NN ._SENT |_SYM The_DT cellular_JJ AAA_NP type_NN ATPase_NP VPS4A_NP ,_, which_WDT is_VBZ a_DT component_NN of_IN the_DT Vps_NP pathway_NN involved_VBN in_IN MVB_NP sorting_VBG ,_, has_VBZ been_VBN shown_VBN to_TO be_VB required_VBN for_IN the_DT release_NN of_IN both_DT HIV-1_NP and_CC MLV_NP ._SENT We_PP therefore_RB wanted_VBD to_TO test_VB whether_IN VPS4A_NP is_VBZ also_RB required_VBN for_IN MPMV_NP budding_VBG and_CC whether_IN the_DT residual_JJ budding_VBG observed_VBD for_IN the_DT MPMV_NP PSAP_NP mutant_NN depends_VBZ on_IN VPS4A_NP function_VBP as_RB well_RB ._SENT For_IN this_DT ,_, we_PP cotransfected_VBD 293T_JJ cells_NNS with_IN wt_NP or_CC PSAP_NP mutant_JJ pMPMV_NN and_CC with_IN either_DT empty_JJ vector_NN ,_, wt_NP GFP-VPS4A_NP ,_, or_CC dominant-negative_JJ GFP-VPS4A_NP mutants_NNS ,_, which_WDT are_VBP defective_JJ for_IN ATP_NP binding_VBG (_( VPS4AK173Q_NP )_) or_CC ATP_NP hydrolysis_NN (_( VPS4AE228Q_NP )_) ._SENT As_IN a_DT control_NN ,_, we_PP also_RB transfected_VBD PPPY_JJ mutant_JJ pMPMV_NN ._SENT As_IN observed_VBN for_IN HeLa_NP cells_NNS ,_, 293T_JJ cells_NNS transfected_VBN with_IN PPPY_JJ mutant_JJ pMPMV_NN exhibited_VBD no_DT virus_NN release_NN (_( Fig._NN ,_, lanes_NNS 1_CD and_CC 2_CD )_) ._SENT In_IN contrast_NN ,_, there_EX was_VBD no_DT significant_JJ phenotype_NN for_IN PSAP_NP mutant_JJ MPMV_NP in_IN 293T_JJ cells_NNS (_( Fig._NN ,_, lanes_NNS 1_CD and_CC 3_CD )_) ,_, indicating_VBG that_IN the_DT requirement_NN for_IN the_DT PSAP_NP motif_NN depends_VBZ on_IN the_DT cell_NN type_NN used_VBD ._SENT Upon_IN cotransfection_NN of_IN wt_NP GFP-VPS4A_NP with_IN pMPMV_NP or_CC the_DT L-domain_NP mutant_JJ plasmids_NNS ,_, less_JJR virus_NN was_VBD released_VBN than_IN from_IN cells_NNS cotransfected_VBN with_IN empty_JJ vector_NN (_( Fig._NN ,_, compare_VBP lanes_NNS 4_CD to_TO 6_CD and_CC lanes_NNS 1_CD to_TO 3_CD )_) ._SENT A_DT similar_JJ finding_NN was_VBD reported_VBN by_IN Garrus_NP et_FW al._FW ,_, who_WP observed_VBD a_DT reduction_NN of_IN virus_NN release_NN upon_IN cotransfection_NN of_IN wt_NP GFP-VPS4A_NP and_CC HIV-1_NP ._SENT Strikingly_RB ,_, cotransfection_NN of_IN either_DT VPS4A_NP mutant_JJ construct_NN reduced_VBD virus_NN release_NN for_IN both_DT wt_JJ pMPMV_NN and_CC the_DT PSAP_NP variant_NN to_TO levels_NNS as_IN low_JJ as_IN that_WDT observed_VBD for_IN the_DT PPPY_JJ mutant_JJ construct_NN (_( Fig._NN ,_, lanes_NNS 7_CD to_TO 14_CD )_) ._SENT Furthermore_RB ,_, in_IN the_DT presence_NN of_IN ATPase-defective_NP VPS_NP 